日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The protein deacetylase SIRT2 exerts metabolic control over adaptive β cell proliferation.

蛋白质脱乙酰酶 SIRT2 对适应性 β 细胞增殖发挥代谢控制作用。

Wortham Matthew, Ramms Bastian, Zeng Chun, Benthuysen Jacqueline R, Sai Somesh, Pollow Dennis P, Liu Fenfen, Schlichting Michael, Harrington Austin R, Liu Bradley, Prakash Thazha P, Pirie Elaine C, Zhu Han, Baghdasarian Siyouneh, Lee Sean T, Ruthig Victor A, Wells Kristen L, Auwerx Johan, Shirihai Orian S, Sander Maike

Engineered vasculature induces functional maturation of pluripotent stem cell-derived islet organoids.

人工血管系统诱导多能干细胞衍生的胰岛类器官的功能成熟

Jun Yesl, Nguyen-Ngoc Kim-Vy, Sai Somesh, Bender R Hugh F, Gong Winnie, Kravets Vira, Zhu Han, Hatch Christopher J, Schlichting Michael, Gaetani Roberto, Mallick Medhavi, Hachey Stephanie J, Christman Karen L, George Steven C, Hughes Christopher C W, Sander Maike

Automation-aided construction and characterization of Bacillus subtilis PrsA strains for the secretion of amylases

自动化辅助构建和鉴定枯草芽孢杆菌 PrsA 菌株以分泌淀粉酶

Felix Hamburger, Niels Schlichting, Michael Eichenlaub, Paul Igor Costea, Christopher Sauer, Stefan Jenewein, Johannes Kabisch

Cost-effectiveness of cetuximab-containing regimens for squamous cell carcinoma of the head and neck in Italy

意大利含西妥昔单抗方案治疗头颈部鳞状细胞癌的成本效益分析

Ivanyi, Philipp; Bullement, Ash; Botticelli, Andrea; Perri, Francesco; Colombo, Giorgio L; Annibali, Viviana; Gandola, Anita; Naik, Jaesh; Schlichting, Michael; Pescott, Chris P

Development of a Conceptual Model of the Patient Experience in Small Cell Lung Cancer: A Qualitative Interview Study

小细胞肺癌患者体验概念模型的构建:一项定性访谈研究

Altman, Danielle E; Zhang, Xinke; Fu, An-Chen; Rams, Alissa R; Baldasaro, Jessica A; Ahmad, Samir Ali; Schlichting, Michael; Marquis, Patrick; Benincasa, Elena; Moulin, Camilo; Pawar, Vivek

Investigating the trends in patient-reported outcomes pre-treatment and implications to efficacy analyses: A post-hoc analysis of a cancer clinical trial

探究治疗前患者报告结局的趋势及其对疗效分析的影响:一项癌症临床试验的事后分析

Schlichting, Michael; Sanz, Hector; Williams, Paul; Ballarini, Nicolas; Rippin, Gerd; Pawar, Vivek

Interpreting Within-Patient Changes on the EORTC QLQ-C30 and EORTC QLQ-LC13

解读 EORTC QLQ-C30 和 EORTC QLQ-LC13 的患者内部变化

Coon, Cheryl D; Schlichting, Michael; Zhang, Xinke

Single-cell chromatin accessibility identifies pancreatic islet cell type- and state-specific regulatory programs of diabetes risk

单细胞染色质可及性可识别胰腺胰岛细胞类型和状态特异性的糖尿病风险调节程序

Joshua Chiou #, Chun Zeng #, Zhang Cheng, Jee Yun Han, Michael Schlichting, Michael Miller, Robert Mendez, Serina Huang, Jinzhao Wang, Yinghui Sui, Allison Deogaygay, Mei-Lin Okino, Yunjiang Qiu, Ying Sun, Parul Kudtarkar, Rongxin Fang, Sebastian Preissl, Maike Sander, David U Gorkin, Kyle J Gaulton

What is the Impact of the Analysis Method Used for Health State Utility Values on QALYs in Oncology? A Simulation Study Comparing Progression-Based and Time-to-Death Approaches

肿瘤学中用于评估健康状态效用值的分析方法对质量调整生命年(QALY)有何影响?一项比较基于疾病进展和基于死亡时间两种方法的模拟研究

Hatswell, Anthony J; Bullement, Ash; Schlichting, Michael; Bharmal, Murtuza

Update on the psychometric properties and minimal important difference (MID) thresholds of the FACT-M questionnaire for use in treatment-naïve and previously treated patients with metastatic Merkel cell carcinoma

关于FACT-M问卷在初治和既往接受过治疗的转移性默克尔细胞癌患者中的心理测量特性和最小重要差异(MID)阈值的最新信息

Bharmal, Murtuza; Nolte, Sandra; Henry-Szatkowski, Mickaël; Hennessy, Meliessa; Schlichting, Michael